documents: FDA-2022-D-2512-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-D-2512-0001 FDA FDA-2022-D-2512 Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived From Cell Lines of Human or Animal Origin; International Council for Harmonisation; Draft Guidance for Industry; Availability Notice Notice of Availability 2022-11-14T05:00:00Z 2022 11 2022-11-14T05:00:00Z   2022-11-14T16:04:58Z 2022-24685 0 0 09000064854aab74

Links from other tables